[HTML][HTML] A comprehensive overview of the clinical relevance and treatment options for antibody-mediated rejection associated with non-HLA antibodies
T Kardol-Hoefnagel, HG Otten - Transplantation, 2021 - journals.lww.com
Although solid organ transplant results have improved significantly in recent decades, a
pivotal cause of impaired long-term outcome is the development of antibody-mediated …
pivotal cause of impaired long-term outcome is the development of antibody-mediated …
A2/A2B to B deceased donor kidney transplantation in the Kidney Allocation System era
SS Bisen, LB Zeiser, SN Getsin, PY Chiang… - American Journal of …, 2024 - Elsevier
Kidney transplantation from blood type A2/A2B donors to type B recipients (A2→ B) has
increased dramatically under the current Kidney Allocation System (KAS). Among living …
increased dramatically under the current Kidney Allocation System (KAS). Among living …
Angiotensin Type 1 Receptor Antibody-Mediated Rejection in a Kidney Transplant Recipient
BA Sarrell, BP Concepcion - … in Kidney Transplantation: A Case-Based …, 2022 - Springer
Antibody-mediated rejection of a kidney allograft can be caused by non-human leukocyte
antigen (HLA) antibodies such as Angiotensin Type 1 Receptor (AT1R) antibodies. AT1R …
antigen (HLA) antibodies such as Angiotensin Type 1 Receptor (AT1R) antibodies. AT1R …
Hepatitis C: Cure for a New Era
JR Eames, B Tran - Physician Assistant Clinics, 2021 - physicianassistant.theclinics.com
It is estimated that approximately 170 million people are infected with the hepatitis C virus
(HCV) globally. 1 This virus contributes to global morbidity and an estimated 1.3 million …
(HCV) globally. 1 This virus contributes to global morbidity and an estimated 1.3 million …